We therefore hypothesised that reducing extracellular matrix remodelling in the pulmonary vascular endothelium by reducing MMP-9 production may also be one of the mechanisms of action of RSR in inhibiting breast cancer lung metastasis. The gene discussed is MMP9; the disease is breast cancer.